Hunter, Bradley D <br/><br/>
Allogeneic Stem Cell Transplantation and Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Non-Hodgkin Lymphoma.  [electronic resource] 

 -  Hematology/oncology clinics of North America  08 2019 
 - 687-705 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1558-1977 
<br/><br/><label>Standard No.: </label>10.1016/j.hoc.2019.03.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Lymphoma, Non-Hodgkin--mortality<br/>Receptors, Chimeric Antigen--therapeutic use<br/>Stem Cell Transplantation--methods<br/>Survival Analysis<br/>Transplantation, Homologous